共 51 条
- [1] Arcelus J(2011)Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies Arch Gen Psychiatry 68 724-731
- [2] Mitchell AJ(2012)Clinical psychopharmacology of eating disorders: a research update Int J Neuropsychopharmacol 15 209-222
- [3] Wales J(2012)Psychotropic medication use in anorexia nervosa between 1997 and 2009 Int J Eat Disord 45 970-976
- [4] Nielsen S(2011)Pharmacotherapy of anorexia nervosa: more questions than answers J Am Acad Child Adolesc Psychiatry 50 854-856
- [5] Hay PJ(2011)Serotonin: imaging findings in eating disorders Curr Top Behav Neurosci 6 59-79
- [6] Claudino AM(2008)Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18 F]MPPF PET scan study Biol Psychiatry 64 1009-1013
- [7] Fazeli PK(1999)The reliability of the Eating Disorder Examination-Self-Report Questionnaire Version (EDE-Q) The International Journal Of Eating Disorders 25 349-351
- [8] Calder GL(1999)Autoregulation of serotonin neurons: role in antidepressant drug action Pharmacol Rev 51 533-591
- [9] Miller KK(1990)Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites Biol Psychiatry 28 99-109
- [10] Misra M(1991)Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine–I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission Neuropharmacology 30 679-690